Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorSteiner, Timothy J
dc.contributor.authorKatsarava, Zaza
dc.contributor.authorPozo Rosich, Patricia
dc.contributor.authorGantenbein, Andreas
dc.contributor.authorRoche, Sarah L
dc.contributor.authorTerwindt, Gisela
dc.date.accessioned2022-11-04T08:51:54Z
dc.date.available2022-11-04T08:51:54Z
dc.date.issued2022-11
dc.identifier.citationSteiner TJ, Terwindt GM, Katsarava Z, Pozo-Rosich P, Gantenbein AR, Roche SL, et al. Migraine-attributed burden, impact and disability, and migraine-impacted quality of life: Expert consensus on definitions from a Delphi process. Cephalalgia. 2022 Nov;42(13):1387–96.
dc.identifier.issn1468-2982
dc.identifier.urihttps://hdl.handle.net/11351/8395
dc.descriptionDelphi; Migraine; Disability
dc.description.abstractBackground Migraine-attributed burden, impact, disability and migraine-impacted quality of life are important concepts in clinical management, clinical and epidemiological research, and health policy, requiring clear and agreed definitions. We aimed to formulate concise and precise definitions of these concepts by expert consensus. Methods We searched the terms migraine-attributed burden, impact, disability and migraine-impacted quality of life in Embase and Medline from 1974 and 1946 respectively. We followed a Delphi process to reach consensus on definitions. Results We found widespread conflation of concepts and inconsistent terminology within publications. Following three Delphi rounds, we defined migraine-attributed burden as “the summation of all negative consequences of the disease or its diagnosis”; migraine-attributed impact as “the effect of the disease, or its diagnosis, on a specified aspect of life, health or wellbeing”; migraine-attributed disability as “physical, cognitive and mental incapacities imposed by the disease”; and migraine-impacted quality of life as “the subjective assessment by a person with the disease of their general wellbeing, position and prospects in life”. We complemented each definition with a detailed description. Conclusion These definitions and descriptions should foster consistency and encourage more appropriate use of currently available quantifying instruments and aid the future development of others.
dc.language.isoeng
dc.publisherSAGE Publications
dc.relation.ispartofseriesCephalalgia;42(13)
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.sourceScientia
dc.subjectMigranya - Complicacions
dc.subjectQualitat de vida - Avaluació
dc.subjectPresa de decisions
dc.subject.meshMigraine Disorders
dc.subject.mesh/complications
dc.subject.meshQuality of Life
dc.subject.meshConsensus
dc.titleMigraine-attributed burden, impact and disability, and migraine-impacted quality of life: Expert consensus on definitions from a Delphi process
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1177/03331024221110102
dc.subject.decstrastornos migrañosos
dc.subject.decs/complicaciones
dc.subject.decscalidad de vida
dc.subject.decsconsenso
dc.relation.publishversionhttps://doi.org/10.1177/03331024221110102
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Steiner TJ] Department of Neuromedicine and Movement Science, NTNU Norwegian University of Science and Technology, Trondheim, Norway. Division of Brain Sciences, Imperial College London, London, UK. [Terwindt GM] Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands. [Katsarava Z] Christian Hospital Unna, Unna, Germany. Department of Neurology, University of Duisburg-Essen, Essen, Germany. EVEX Medical Corporation, Tbilisi, Georgia. [Pozo-Rosich P] Unitat de Cefalea, Servei de Neurologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Recerca en Cefalea, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Gantenbein AR] Department of Neurology, ZURZACH Care, Bad Zurzach, Switzerland. Neurological Practice, Neurologie am Untertor, Bülach, Switzerland. Department of Neurology, University Hospital Zurich, Zürich, Switzerland. [Roche SL] Eli Lilly and Company, Cork, Ireland
dc.identifier.pmid35791285
dc.identifier.wos000821252800001
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record